Kirin-Amgen Inc. v Transkaryotic Therapies Inc. (No.1)
| Jurisdiction | England & Wales |
| Neutral Citation | [2001] EWHC 433 (Pat) |
| Date | 2001 |
| Court | Chancery Division (Patents Court) |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
11 cases
-
Halliburton Energy Services Inc. v Smith International (North Sea) Ltd
...... on what Neuberger J called the ‘classical’ basis in Kirin Amgen v TKT , I do not propose to say more than to observe that this particular ......
-
Warner-Lambert Company LLC v Generics (UK) Ltd (trading as Mylan) and Others
...that which would render it invalid.” 94 More recently, the same point was made by Neuberger J in Kirin-Amgen Inc v Roche Diagnostics GMBH [2002] RPC 1, para 286. There is also substantial support for it in other common law jurisdictions. It was adopted by the Supreme Court of the United Sta......
-
Generics (UK) Ltd v H Lundbeck A/S
...least where they are claims to chemical compounds). I made exactly the same mistake at first instance in the Kirin-Amgen case - see at [2002] RPC 1, paras 300-312. A number of articles to which reference was made in the written cases also appear to have proceeded upon the same 101 It may b......
-
Generics (U.K.) Ltd. et al. v. H. Lundbeck A/S, [2009] N.R. Uned. 179
...(at least where they are claims to chemical compounds). I made exactly the same mistake at first instance in the Kirin-Amgen case - see at [2002] RPC 1, paras. 300-312. A number of articles to which reference was made in the written cases also appear to have proceeded upon the same view. [1......
Request a trial to view additional results
2 firm's commentaries
-
UK Supreme Court Confirms Warner-Lambert Patent Claims Insufficient
...was considered in patent contexts in Parkinson v Simon (1895) 12 RPC 403 (House of Lords), Kirin-Amgen Inc v Roche Diagnostics GMBH [2002] RPC 1 (Neuberger J) and Smithkline Beecham plc's Patent [2003] EWCA Civ 872. Lord Briggs also noted dicta from the United States, Canada and Lord Briggs......
-
Intellectual Property – More Materials
...means which owe nothing to the teaching of the patent or any principle it disclosed. The Patents Court in Kirin-Amgen v Roche Diagnostics [2002] RPC1 referred to these two grounds for insufficiency in a patent as “classic insufficiency” and “Biogen insufficiency”, but the Court of Appeal sa......